v3.22.2.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Revenue $ 217,127 $ 138,743 $ 531,389 $ 373,364
Operating expenses:        
Cost of product sales, excluding amortization of acquired intangible assets 14,011 6,539 33,785 23,001
Amortization of intangible assets 31,023 14,383 80,790 38,411
Research and development 165,462 130,845 462,802 390,840
Selling, general and administrative 80,118 69,252 233,280 199,225
Change in the fair value of deferred and contingent consideration (5,300) 10,800 (32,200) 11,600
Total operating expenses 285,314 231,819 778,457 663,077
Loss from operations (68,187) (93,076) (247,068) (289,713)
Interest expense, net (20,880) (21,802) (66,371) (63,520)
Other expense, net (38,141) (18,782) (84,355) (26,499)
Loss before income tax expense (127,208) (133,660) (397,794) (379,732)
Income tax benefit (expense) 17,893 36 9,666 (904)
Net loss attributable to common stockholders $ (109,315) $ (133,624) $ (388,128) $ (380,636)
Weighted-average shares outstanding:        
Basic 71,654,671 70,585,938 71,415,849 70,397,846
Diluted 71,654,671 70,585,938 71,415,849 70,397,846
Net loss per share-basic and diluted (in dollars per share)        
Basic $ (1.53) $ (1.89) $ (5.43) $ (5.41)
Diluted $ (1.53) $ (1.89) $ (5.43) $ (5.41)
Net product revenue        
Revenues:        
Revenue $ 134,186 $ 115,605 $ 407,720 $ 309,998
Collaboration revenue        
Revenues:        
Revenue 50,017 10,011 50,024 30,018
Royalty revenue        
Revenues:        
Revenue $ 32,924 $ 13,127 $ 73,645 $ 33,348